Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Share of Home Sales With Concessions in Quarter Through August Hits Highest for That Period Since At Least 2020, Redfin Says

Share of Home Sales With Concessions in Quarter Through August Hits Highest for That Period Since At Least 2020, Redfin Says

MT newswireMT newswire2026/09/18 19:15
03:15 PM EDT, 09/18/2026 (MT Newswires) -- The share of US home sales in the quarter through August in which sellers gave concession to buyers reached the highest for that period since at least 2020, Redfin said Friday. Sellers gave concessions in 44.7% of deals during the three months ended Aug. 31, up from 42.6% a year earlier and marking the highest share for the period since at least 2020, the online real estate brokerage said. A concession is considered anything that a seller provides to help reduce a buyer's total cost of purchasing a home, but excludes a lower listed price or price reductions due to negotiations, according to Redfin. The period marked the strongest buyer's market since 2013, as a growing supply of homes met a shrinking pool of active buyers. Sellers are offering to handle closing costs, cover repair bills, or add extra incentives to close a deal, the report showed. "Buyers know they can be picky. They're asking for every concession under the sun," said Amanda Peterson, a Redfin Premier agent in Dallas. "That's especially true for newly built homes. Builders are offering $10,000 or $20,000 in concessions, buying down mortgage rates and throwing in appliances." Eight of the 10 markets where concessions are most common were in the Sun Belt, led by Atlanta, where sellers offered concessions in 72.8% of the deals. Concessions were least common in strong housing markets like the Bay Area and New York, led by San Jose, California, where just 4.2% of sellers gave concessions, according to Redfin. Some 15.8% of US homes that sold in the three months through August had a price drop in addition to a concession, also the highest share for that period, the brokerage said. Separately, Zillow Group (Z, ZG) said Friday it now expects its count of existing home sales to drop 3.5% year over year in the fourth quarter, compared with its prior outlook of a 3.2% decrease. For the full-year, the firms expects sales to rise 1.2% from 2025, it said in its report. Earlier this week, the National Association of Home Builders and Wells Fargo said US homebuilder confidence this month hit its lowest level since September 2025 amid elevated mortgage rates and increasing material costs. Price: 30.04, Change: -0.06, Percent Change: -0.20
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53